These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17338046)

  • 1. Chronic kidney disease, anemia, and epoetin.
    Go AS; Ayus JC
    N Engl J Med; 2007 Mar; 356(9):957; author reply 958-9. PubMed ID: 17338046
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease, anemia, and epoetin.
    Riley DS
    N Engl J Med; 2007 Mar; 356(9):956; author reply 958-9. PubMed ID: 17329706
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic kidney disease, anemia, and epoetin.
    Ashrani AA; Rajkumar SV
    N Engl J Med; 2007 Mar; 356(9):957-8; author reply 958-9. PubMed ID: 17338048
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of anemia--payoffs and problems.
    Remuzzi G; Ingelfinger JR
    N Engl J Med; 2006 Nov; 355(20):2144-6. PubMed ID: 17108347
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic kidney disease, anemia, and epoetin.
    Roger SD
    N Engl J Med; 2007 Mar; 356(9):958; author reply 958-9. PubMed ID: 17338047
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic kidney disease, anemia, and epoetin.
    Mikhail A; Goldsmith D
    N Engl J Med; 2007 Mar; 356(9):956-7; author reply 958-9. PubMed ID: 17338045
    [No Abstract]   [Full Text] [Related]  

  • 7. Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
    Drüeke TB; Locatelli F; Clyne N; Eckardt KU; Macdougall IC; Tsakiris D; Burger HU; Scherhag A;
    N Engl J Med; 2006 Nov; 355(20):2071-84. PubMed ID: 17108342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
    Jones M; Schenkel B; Just J
    Int J Cardiol; 2005 Apr; 100(2):253-65. PubMed ID: 15823633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin bubble: a severe German case Honi soit qui mal y pense.
    Wizemann V
    Nephrol Dial Transplant; 2011 May; 26(5):1750-2; author reply 1752. PubMed ID: 21378149
    [No Abstract]   [Full Text] [Related]  

  • 10. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of anemia in chronic kidney disease--strategies based on evidence.
    Marsden PA
    N Engl J Med; 2009 Nov; 361(21):2089-90. PubMed ID: 19880845
    [No Abstract]   [Full Text] [Related]  

  • 12. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease.
    Shah HH; Fishbane S
    Adv Chronic Kidney Dis; 2019 Jul; 26(4):267-271. PubMed ID: 31477257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
    Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
    J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative mortality and epoetin alpha dose among hemodialysis patients.
    Coyne DW
    Am J Kidney Dis; 2008 May; 51(5):866-7; author reply 867. PubMed ID: 18436101
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative mortality and epoetin alpha dose in hemodialysis patients.
    Cotter DJ; Thamer M; Zhang Y
    Am J Kidney Dis; 2008 May; 51(5):865; author reply 865-6. PubMed ID: 18436099
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoiesis-stimulating agents--time for a reevaluation.
    Unger EF; Thompson AM; Blank MJ; Temple R
    N Engl J Med; 2010 Jan; 362(3):189-92. PubMed ID: 20054037
    [No Abstract]   [Full Text] [Related]  

  • 20. Darbepoetin alfa and chronic kidney disease.
    Wright RJ; Kanagasundaram NS; Quinton R
    N Engl J Med; 2010 Feb; 362(7):653; author reply 655. PubMed ID: 20164489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.